RESEARCH FOCUS

Current research tends to focus on two major aspects

gut microbiota modulation through characterization

of inflammatory bacteria and changes in gutbrain

communication

FOUNDATION

AWARDS

10 national IBD

*

and IBS

**

grants

1 international grant

KEY FIGURE

people in France were treated in 2020

for a chronic inflammatory bowel disease,

and 53% of them were women

(4)

.

Inflammatory bowel diseases are

characterized by inflammation of

the lining of the digestive tract, due

to deregulation of intestinal immune

defenses. Changes in the composition

and functions of the microbiota have

now been confirmed.

FOCUS ON IRRITABLE BOWEL

SYNDROME

Irritable Bowel Syndrome (IBS), characterized by

abdominal pain and a change in bowel habits, is the most

common functional bowel disorder. The causes of this

syndrome have not yet been determined. However, a loss

of microbiota diversity has been pinpointed, opening up

exciting new therapeutic options.

WHAT IS IT?

DYSBIOSIS

Dysbiosis can be defined as an

alteration in the composition

and function of the microbiota

(3)

.

Dysbiosis of the gut microbiota has been observed

in many diseases. Is it the cause or the consequence?

That remains to be seen...

*

Inflammatory Bowel Diseases,

**

Irritable Bowel Syndrome.

18